Panbela Therapeutics Entered Into Agreements With Certain Stockholders For $2M Private Placement Of Existing Warrants Exercisable For 2,556,000 Of Its Common Stock, In Aggregate, To Exercise Outstanding Warrants At $0.78/Share In Exchange For New Warrants
Benzinga Newsdesk - Dec 21, 2023, 9:30AM